Regener-Eyes® LLC, a leading name in the ophthalmic industry, is registered, regulated, inspected and in full compliance with all FDA regulations. Regener-Eyes® is dedicated to safety, quality, and compliance.
The American Society of Retina Specialists (ASRS) invites members of the press to cover the latest advances in retina science and practice during its 42nd Annual Scientific Meeting July 17-20, 2024.
An eye movement study led by a New York Institute of Technology psychology researcher suggests that techniques used in a Baroque-era painting could help today’s marketers catch the attention of modern consumers.
As people prepare to thrill at the phenomenon of the eclipse today, Lauren Lusardi, OD, FAAO, an optometrist with Atlantic Health System in New Jersey, breaks down how the event makes us susceptible to eye damage and useful tips on how to protect yourself.
The April 8 solar eclipse—a spectacular show in the sky when the moon will pass in front of the sun—is almost here. University of Miami ophthalmologists explain how to view it safely.
The Wilmer Eye Institute, Johns Hopkins Medicine has received two awards totaling more than $20 million from the National Eye Institute at the National Institutes of Health, both of which will be used for a six-year clinical trial investigating a potential treatment for the most common inherited retinal disease, retinitis pigmentosa.
It’s a celestial anomaly that happens only once in a blue moon. A Penn State Health expert talks about the safest ways for you to witness the solar eclipse on Monday, April 8.
Findings from a National Eye Institute-supported study show for the first time that when babies look at photos of unfamiliar everyday scenes, such as an office or a lab, they tend to fixate on the same regions where adults find meaning. This inclination to home in on what’s interesting or meaningful grows more pronounced as babies age. The findings, published in Infancy, provide a more nuanced understanding of visual development, which may lead to earlier detection of brain-based causes of vision problems, such as cerebral/cortical visual impairment.
National Eye Institute researchers studying human retinas discovered 87 target genes where a mix of environmental factors likely influence one’s risk of developing age-related macular degeneration (AMD), a leading cause of vision loss in people ages 65 and older.
Researchers have used advanced sequencing technology to determine how the mix of microbes present in patients with healthy eyes differs from the mix found in patients with dry eye.
Leaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
The Shaffer Prize recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to better understand and cure glaucoma.
On April 8, 2024, 40 million people across the United States, Canada, and Mexico will have the opportunity to experience a true celestial spectacle, a rare total solar eclipse as the moon passes between the sun and the Earth, blocking daylight for several minutes.
Millions face vision loss from AMD, yet access to crucial services, assistive devices, and care remain a hurdle. AMDF declares the 4th week of February Access in Sight! AMD Advocacy and Action Week (Feb 25th-29th) to mobilize efforts and demand change for the macular degeneration and low vision community. #AccessinSight
Wake Forest University School of Medicine has launched a new Translational Eye and Vision Research Center, located inside Biotech Place, in Innovation Quarter in Winston-Salem, North Carolina. Leaders envision the center serving as a visionary hub that will redefine the landscape of eye and vision research.
Chao Zhou, a professor of biomedical engineering in the McKelvey School of Engineering at Washington University in St. Louis, has been awarded an up to $20 million contract from the Advanced Research Projects Agency for Health (ARPA-H).
The Korea Institute of Science and Technology (KIST) announced that Dr. Maesoon Im of the Brain Science Institute, together with Prof. Seung Ja Oh of Kyung Hee University and Prof. Kangwon Lee of Seoul National University, successfully incorporated anti-inflammatory drugs into a hydrogel to suppress inflammation in the retina and effectively deliver the drugs to the inflamed area.
Rockville, Md. - The Association for Research in Vision and Ophthalmology (ARVO) announced today the 2023 recipients of its annual Advocacy Awards: Achievements in Eye and Vision Advocacy Award ― Roxanne Crosby-Nwaobi, RN, PhD, (Moorfields National Institute for Health and Care Research (NIHR) Biomedical Research Centre, U.K.) and Rohan Bir Singh, MD (Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, U.S.)
A new study, by the University of Portsmouth in England and Naresuan and Pibulsongkram Rajabhat universities in Thailand, suggests a naturally-occurring material is an effective disinfectant for contact lenses and could help millions of people worldwide.
The research team investigated the four extracellular matrix proteins Brevican, Neurocan, Tenascin-C and Tenascin-R, which occur in the cell environment of nerve cells of the retina.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation has named David A. Atchison, PhD, DSc, as the 2024 recipient of the Oberdorfer Award in Low Vision.
The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today that Sally L. Baxter, MD, MSc, is the 2024 recipient of the Ludwig von Sallmann Clinician-Scientist Award.
AMDF and TLI launch a campaign to raise awareness about macular degeneration with the official release of a short film featuring TLI fellow Laura Carabello.
New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease. The University of Bristol-led research is published in Cardiovascular Diabetology.
A 2024 AMD Awareness Month Resource Page, designed for the public and journalists, offers educational content, shareable talking points, fact sheets, shareable social media graphics, videos, opportunities for action, and more.
As executive vice president from 1993 to 2009, Dr. Hoskins grew the American Academy of Ophthalmology into the world’s largest association of eye physicians and surgeons and guided it into the digital era, with the goal of providing ophthalmologists worldwide with resources to improve ophthalmic care and their patients’ lives.
Working with mammalian retinal cells, neuroscientists at Johns Hopkins Medicine have shown that, unlike most light-sensing cells (photoreceptors) in the retina, one special type uses two different pathways at the same time to transmit electrical “vision” signals to the brain.
Alyssa L. Lie, PhD, BOptom (University of Auckland, New Zealand) and Tarsis Gesteira Ferreira, MSc, PhD (University of Houston, Texas) have been named the inaugural recipients of the ARVO Foundation Research Catalyst Awards.
The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Neil Lagali, PhD (Linköping University, Sweden) and Mehrdad Rafat, PhD (LinkoCare Life Sciences AB /NaturaLens AB, Sweden) — recipients of the 2023 Point of View Award.